Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury
Cardiovascular Drugs and Therapy · 2026-12 · 40 (6) · 2241-2259
DOI: 10.1007/s10557-026-07922-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 10.08.2026. Verfasst von Yonglin Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 5…. Hauptthemen laut MEDLINE: MicroRNAs, Myocardial Reperfusion Injury, Ferroptosis, Mixed Function Oxygenases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: the General Program of the Natural Science Foundation of Xinjiang Uygur Autonomous Region, the Characteristic Innovation Project of Ordinary Universities in Guangdong Province.
Abstract (Originalsprache)
Ferroptosis plays a critical role in myocardial ischemia-reperfusion injury (MIRI). Here, we discovered that MSMO1, a key enzyme in the cholesterol biosynthesis pathway, regulates ferroptosis in MIRI, and identified miR-26a-5p as an upstream regulator of MSMO1. During MIRI, downregulation of miR-26a-5p led to suppression of MSMO1, reduction of 7-DHC accumulation, and promotion of lipid peroxidation and ferroptosis. To translate this mechanism, we developed engineered exosomes delivering miR-26a-5p. In cellular and mouse MIRI models, this intervention significantly attenuated serum levels of cardiac injury biomarkers (cTnI and CK-MB), restored systemic antioxidant capacity, and attenuated early myocardial fibrosis. This work provides a novel therapeutic strategy for MIRI and provides preclinical evidence supporting the potential of engineered exosomes as a cell-free therapeutic platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China.
- School of Medicine, Kashi University, Kashi, 844000, China.
- School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China. jiangm528@gdmu.edu.cn.
- School of Basic Medical Sciences, Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China. cuixiaojun@gdmu.edu.cn.
- School of Medicine, Kashi University, Kashi, 844000, China. cuixiaojun@gdmu.edu.cn.
Förderung
- the General Program of the Natural Science Foundation of Xinjiang Uygur Autonomous Region
- the Characteristic Innovation Project of Ordinary Universities in Guangdong Province
Zitieren
APA
Fu, Y., Han, B., Zhang, J., Liu, L., Chen, W., Kuang, C., Jiang, M., & Cui, X. (2026). Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury. Cardiovascular Drugs and Therapy, 40(6), 2241-2259. https://doi.org/10.1007/s10557-026-07922-2
Vancouver
Fu Y, Han B, Zhang J, Liu L, Chen W, Kuang C, et al. Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury. Cardiovascular Drugs and Therapy. 2026;40(6):2241-2259. doi:10.1007/s10557-026-07922-2
BibTeX
@article{Fu2026,
author = {Fu, Yonglin and Han, Bingjie and Zhang, Jiankai and Liu, Lu and Chen, Wenjie and Kuang, Ciying and Jiang, Mei and Cui, Xiaojun},
title = {Unveiling the miR‑26a‑5p/MSMO1/7‑DHC Axis: A Novel Therapeutic Target in Myocardial Ischemia-Reperfusion Injury},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
volume = {40},
number = {6},
pages = {2241--2259},
doi = {10.1007/s10557-026-07922-2}
}
EUVIMED